Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers

Lignende værker

• Effect of Low-Dose Ritonavir on the Pharmacokinetics of the CXCR4 Antagonist AMD070 in Healthy Volunteers
  af: Cao, Ying Jun, et al.
  Udgivet: (2008)
• The CXCR4 Antagonist AMD3100 Efficiently Inhibits Cell-Surface-Expressed Human Immunodeficiency Virus Type 1 Envelope-Induced Apoptosis
  af: Blanco, Julià, et al.
  Udgivet: (2000)
• AMD3100, a CxCR4 Antagonist, Attenuates Allergic Lung Inflammation and Airway Hyperreactivity
  af: Lukacs, Nicholas W., et al.
  Udgivet: (2002)
• Suppression of Dualtropic Human Immunodeficiency Virus Type 1 by the CXCR4 Antagonist AMD3100 Is Associated with Efficiency of CXCR4 Use and Baseline Virus Composition
  af: Fransen, Signe, et al.
  Udgivet: (2008)
• Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
  af: Nervi, Bruno, et al.
  Udgivet: (2009)